The prognostic value of HOXA9 promoter methylation was associated with lung cancer and can become a new diagnostic and prognostic biomarker for predicting the prognosis of stage I lung adenocarcinoma 37. This evidence concerns the gene HOXA9 and lung adenocarcinoma.